Weight loss drug fill rates

Pricey weight loss drugs lose some disciples in 2024
People struggling with their body weight experienced joy when new, more effective prescription drug options became the rage in 2023, but it seems many folks stopped taking them in 2024.
Where weight-loss drugs are popular in the U.S. in 2024
Prescriptions for weight-loss drugs surged in 2024 and were much more popular in some states, particularly those in the South with higher rates of obesity.
Prices on weight loss drugs are dropping — What patients need to know
Despite this escalating demand for popular GLP-1 drugs, the prices for some of these products are actually dropping. Dr. Faith Coleman explains.
Age and the new weight-loss drugs
Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?
Elon Musk is on the weight loss drug bandwagon
Elon Musk, the richest person alive and the co-head of President-elect Donald Trump’s new Department of Government Efficiency (DOGE), is doubling down on his support for expanding access to affordable GLP-1 weight-loss medications like Ozempic.
Scientists Uncover New Cardiovascular Benefits of Popular Weight Loss Drugs
New studies in JACC highlight improvements in cardiac structure and function among CABG patients, as well as changes in cardiac risk biomarkers linked to lifestyle interventions. New research published in JACC,
Zepbound Vs. Wegovy: Which Is Better for Weight Loss?
For the uninitiated, both Zepbound (tirzepatide) and Wegovy (semaglutide) are weight loss drugs. They target hormones that influence metabolism and appetite, but they operate through different mechanisms.
Is Zepbound or Wegovy Better for Weight Loss? One Can Help You Shed 50 Lbs
With so many weight loss medications on the market, it’s easy to feel overwhelmed by the options. From brand-name heavy hitters to compounded varieties, each promises to help shed pounds. But a recent head-to-head trial comparing Zepbound vs.
Weight loss drug fill rates, by state
To assess state-level trends, GoodRx examined fill rates for all medications, excluding vaccines, from a nationally representative sample between Jan. 1 and Oct. 31. The figures below reflect the percentage of total medication fills for GIP and GLP-1 drugs prescribed for either diabetes or weight loss indications.
Science News22h
The benefits of Ozempic and its kin may extend far beyond weight loss
Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.
West Virginia’s Weight-Loss Experiment
For the state, the cost of funding obesity medications was too high. For the patients, the cost of losing access is higher.
‘Lifting from head to toe’: Weight-loss drugs boost popularity of surgeries to remove extra skin
Thanks to effective and popular new drugs for weight loss and diabetes – an estimated 1 in 8 adults in the US has used ...
Weight-loss drugs deliver life-changing health benefits - and big profits
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Elon Musk shows support for weight loss drugs despite RFK Jr.'s criticism
Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.
Weight loss costs: Iowans struggle with insurance and access to ozempic, other GLP-1 drugs
Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...